InvestorsHub Logo
Followers 31
Posts 6562
Boards Moderated 0
Alias Born 01/20/2016

Re: frrol post# 398631

Tuesday, 01/17/2023 9:31:38 AM

Tuesday, January 17, 2023 9:31:38 AM

Post# of 470701
frrol--look again---Dec.1 PR on Anavex website- "2-73 met the primary endpoints ADAS-Cog[1] and ADCS-ADL[2] and key secondary endpoint CDR-SB[3] with statistically significant results. Next step, in light of this data, is meeting with regulatory authorities to discuss this data in the context of ongoing development with an aim to bring this therapy to patients in Europe, Asia-Pacific, and the U.S." Ongoing talks with regulators---this drug works !! WGT !!!!
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News